Recent Updates
Recently added Catalysts
XTNT Positive Sentiment

Xtant Medical to Issue Second Quarter 2023 Financial Results on August 1, 2023

Tuesday, July 25, 2023 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Xtant Medical Holdings, Inc. has announced the release date for its financial results for the second quarter of 2023, which will be on August 1, 2023. The company specializes in surgical solutions for spinal disorders. This announcement is part of their commitment to keeping stakeholders informed about their financial performance.
Price reaction · baseline $0.861 (2023-07-25 close) · hit after-hours · 2 other XTNT headline(s) in the window, move may be shared
day 0 close · peak
+4.1%

Market Sentiment Analysis

POSITIVE FACTORS

  • Xtant Medical is focusing on surgical solutions for spinal disorders.
  • The upcoming financial results may indicate growth and progress.
  • The announcement reflects transparency and communication with stakeholders.

Full Press Release Details

BELGRADE, Mont. , July 25, 2023 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the second quarter ended

Frequently Asked Questions

When will Xtant Medical release its Q2 2023 results?

Xtant Medical will release its financial results on August 1, 2023.

What is Xtant Medical focused on?

Xtant Medical focuses on surgical solutions for spinal disorders.

ShareAdd on Google
Tags: XTNT Viatris Investor Conferences Healthcare Xtant Medical financial results spinal disorders surgical solutions
Last updated: Jul 25, 2023

Biotech snapshot

Cash runway
$10M liquidity · $2M/mo burn
~4 mo
High dilution risk